AKT1 and chronic obstructive pulmonary disease: Recently, studies have demonstrated that inhibiting the PI3K/Akt signaling pathway reduces inflammation, apoptosis, and oxidative stress in cells, thereby playing a crucial role in COPD treatment (Sun et al., 2019).